1993

Medimiks Ltd. was founded by Dr. Hakki Kumusoglu in Istanbul

1999

GenMer Genetic Diseases  & Prenatal Diagnosis Centre, one of  the first private genetics labs of  Turkey was founded by  Dr.  Hakki Kumusoglu and starting to work together with Medimiks under the same roof.

2000

Medimiks became the distributor of  Vysis Inc., the pioneer and the market leader in FISH probes business worldwide.

2002

After the acquisition of  Vysis by Abbott, Medimiks started to work as an authorised dealer of Abbott -Turkey for FISH probes sales.  Medimiks also moved its headquarters to the European side of Istanbul and opened the branch of  GenMer  Lab. in that new location in order to provide better service to both sides of the city.

2003

Medimiks and a French R&D laboratory, ATL R&D sarl. decided to merge their companies and formed the two new companies located in Paris and Istanbul. The aim of this new structure was working together in the field of biotechnology and provide advanced technology and complete product mix to IVF and genetics laboratories. 

2005

Medimiks became the distributor of Bioview’s automated FISH scanning and analysis systems. 

2006

Medimiks’s microarray development project was supported by TUBITAK-TEYDEB (The Scientific & Technological Research Council of Turkey - Technology and Innovation Funding Programs Directorate). With the partnership of  Medimiks, a new technopark company, OKSANTE Inc. was established  in order to do research for the development  of  oxidative stress analysis methods and antioxidants.

2007

Medimiks’s microarray development project was supported by TUBITAK-TEYDEB (The Scientific & Technological Research Council of Turkey - Technology and Innovation Funding Programs Directorate). With the partnership of  Medimiks, a new technopark company, OKSANTE Inc. was established  in order to do research for the development  of  oxidative stress analysis methods and antioxidants.

2008

Another research project of Medimiks (Turkey) and ATL(France)  was supported by EUREKA (European Research Coordination Agency) which was the first EUREKA support for a project with a Turkish parent company in the field of biological sciences. OKSANTE’s  rapid oxidative stress screening kit  development  project was also  suported by TUBITAK-TEYDEB.  

2010

Medimiks and OKSANTE’s joint  R&D Labs and Medimiks’ headquarters moved back  to Istanbul city center. Medimiks received  ISO13485  certificate for medical device production. 

2011

Medimiks’  36  products was approved by Turkish Ministry of Health.

2014

The number of products approved by MoH reached to 470. Medimiks and  OKSANTE started to move a part of their R&D Lab to the newest technology development zone named Technopark Istanbul.